欧洲和中东慢性疼痛脊髓刺激装置市场复合年增长率为 7.3%,2022 年至 2031 年达到 15.7367 亿美元

Publication Month : Nov 2023

  • Report Code : TIPRE00030317
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 204
Inquire Before Buy

PRICING

$3550

$2840

用于慢性疼痛的脊髓刺激装置市场规模预计将从2022年的8.9266亿美元增长到2030年的15.7367亿美元;预计 2022 年至 2030 年市场复合年增长率为 7.3%。

分析师观点

欧洲和中东用于慢性疼痛的脊髓刺激设备市场分析解释了驱动因素,例如脊髓损伤 (SCI) 数量的增加以及欧洲创新治疗方法的可用性联盟(欧盟)。此外,基于植入物的再生和创新治疗方法预计将在 2022 年至 2030 年期间为市场引入新趋势。从产品类型来看,2022年可充电细分市场将占据更大的市场份额。从应用来看,复杂区域疼痛综合症细分市场在欧洲和中东慢性疼痛脊髓刺激设备市场中占据最大份额,占据主导地位。 2022年。就最终用户而言,在预测期内,医院部门可能会在欧洲和中东占据相当大的市场份额。

脊髓刺激设备是一种植入设备,通过将低电平电信号直接传输到脊髓来缓解疼痛。刺激器主要在非手术疼痛治疗无法充分缓解疼痛后使用。此外,该设备可以改善整体生活质量和睡眠质量。由于它通常与其他疼痛管理治疗一起开出,因此可以有效抑制对止痛药的需求。

市场洞察

脊髓损伤数量的增加支撑了欧洲和中东慢性疼痛市场的脊髓刺激装置

根据脊髓损伤研究、康复和重返社会协会(英国 Aspire)发布的一份报告显示,英国每年约有 2,500 人被诊断患有脊髓损伤 (SCI)。目前,该国约有 50,000 人患有 SCI。根据美国国立卫生研究院 (NIH) 的报告,病例数量增加归因于新兴的摩托车越野赛和摩托车比赛成为英国最受欢迎的体育活动。随着青年和老年人群体中赛车运动活动的增加,这些赛事参与者中脊髓损伤的发生率也随之增加。脊髓损伤对受伤患者及其家人有着改变生活的影响。随着脊髓损伤发病率的上升以及医院对患者进行相应的治疗,每年至少有一名患者再次入院。这是因为 SCI 不会立即得到治疗。再次住院的原因包括呼吸道和尿路感染,以及摩托车运动活动中发生的骨折。

伦敦脊髓损伤中心 (LSCIC) 是英国 11 个组织之一。英国致力于治疗 SCI 患者。在 LSCIC,患者接受为期数年的康复计划,最好通过终身干预来实施。随着脊髓损伤的增加以及提供康复计划的治疗中心拥有完善的基础设施,专业中心或康复中心对脊髓刺激设备的需求激增,从而推动了市场的增长。

未来趋势

基于植入的再生和创新治疗方法

< p>马德里自治区声称是欧盟第一个利用细胞和再生疗法提供脊髓损伤治疗的机构。再生医学包括从 SCI 患者身上提取间充质干细胞,在细胞生产室中处理提取的细胞,然后将再生细胞注射到 SCI 的确切部位或脑脊液 (CSF) 中。因此,该技术可作为 SCI 的个性化治疗方法。

欧盟委员会于 2022 年 9 月发布的一份报告显示,科学家正在开发使用基于石墨烯的植入物治疗 SCI 的新方法和虚拟现实 (VR) 插图,帮助改善中风康复。他们正在尝试这些新方法来逆转神经损伤,而一些研究人员正在尝试使用石墨烯等工程材料原位重塑脊髓的结构。石墨烯用于创建 3D 结构,可以巧妙地模仿脊髓的形态。因此,使用这种创新的工程材料和植入物成功地展现了对 SCI 患者的治疗潜力。基于植入物的再生和创新治疗方法正在成为欧洲和中东慢性疼痛脊髓刺激设备市场的新趋势。

战略见解< /strong>

报告细分和范围

基于产品的见解< /strong>

根据产品类型,慢性疼痛市场的脊髓刺激装置分为可充电式和不可充电式。可充电细分市场在 2022 年占据最大的市场份额,预计该细分市场将在 2022 年至 2030 年期间实现显着的复合年增长率。脊髓刺激器是一种植入式设备,可将低强度电信号直接发送到脊髓中以缓解疼痛。脊髓刺激主要用于非手术疼痛治疗无法充分缓解疼痛后。一些顶级制造商过去已经推出了创新的可充电脊髓刺激设备。 2022 年 12 月,雅培 (Abbott) 获得美国食品和药物管理局 (FDA) 批准,生产世界上最小的可植入式可充电脊髓刺激系统,用于治疗慢性疼痛。

基于应用的见解

基于应用,慢性疼痛市场的脊髓刺激设备是分为失败背部综合症、复杂区域疼痛综合症、退行性椎间盘疾病等。复杂区域疼痛综合征细分市场在 2022 年占据最大的市场份额,预计该细分市场在 2022 年至 2030 年期间复合年增长率最高。复杂区域疼痛综合征 (CRPS) 涉及因受伤或其他医疗事件(例如手术、外伤、中风和心脏病)而发生的长期疼痛和炎症。 CRPS 可发生在身体的任何部位,通常影响手臂、腿、手或脚。女性多发,任何年龄的人均可发生,40岁后炎症达到高峰。大多数 CRPS 病例是由于小周围 C 纤维神经纤维受损或功能不正常引起的,这些神经纤维将疼痛信息传递到大脑。 CRPS 经常因微小血栓的形成而未被诊断出来,有时会阻塞流向神经的血液并使其受伤。

基于最终用户的见解

从最终用户来看,慢性疼痛市场的脊髓刺激设备分为医院、门诊手术中心等。医院细分市场将在 2022 年占据更大的市场份额,预计 2022 年至 2030 年复合年增长率将更高。

医院广泛采用脊髓刺激设备来治疗患有 SCI 的患者。这些设备是通过小手术植入的,该手术通常作为门诊手术进行,然后患者在医院过夜。医院基础设施设备齐全,可以成功使用脊髓刺激器等植入式设备,这些设备在植入后将温和的电脉冲直接传输到患者的神经纤维中,从而减轻慢性疼痛。

用于慢性疼痛市场的脊髓刺激装置,按产品类型划分 - 2022年和2030年

区域分析

欧洲慢性疼痛脊髓刺激设备市场细分为瑞典、波兰、比利时、捷克共和国、希腊、爱尔兰、法国、英国、瑞士、意大利、西班牙、荷兰、斯洛伐克、德国和欧洲其他国家。中东慢性疼痛脊髓刺激设备市场细分为沙特阿拉伯、土耳其、以色列、阿联酋、卡塔尔和中东其他地区。在欧盟,德国在慢性疼痛脊髓刺激设备市场中贡献了很大份额。根据 NIH 的报告,SCI 在德国更为普遍。因此,越来越多的 SCI 相关健康损伤被送往 SCI 中心进行康复治疗。这些专业中心遍布全国各地,提供物理、职业、运动治疗以及物理医学等服务。海德堡大学医院是一家国际公认的专科中心,为脊髓损伤患者提供门诊和住院治疗。专业中心提供的此类创新治疗引发了德国对脊髓刺激设备的需求。

在中东,沙特阿拉伯占脊髓刺激设备的主要份额针对慢性疼痛市场。根据《国际医学研究杂志》2019 年报告,健康科学,沙特阿拉伯是世界上脊髓损伤发病率最高的国家之一。如此高的 SCI 负担主要是由于道路交通事故 (RTA) 不断增加。例如,全国男性SCI患者中有43.9%患有颈椎损伤,其次是胸椎损伤和腰椎损伤,分别为40.4%和3.5%。此外,据称身体和心理困扰是沙特阿拉伯患者发生脊髓损伤的主要原因。然而,早期治疗和康复可以减轻 SCI 的长期并发症,包括住院时间,而预防是患者护理的主要内容。沙特阿拉伯建造了各种康复中心,作为现代医疗保健服务的一部分,以克服脊髓损伤高发带来的挑战。沙特阿拉伯王国(KSA)有多家康复医院/中心,主要分布在大城市。其中包括利雅得苏丹亲王军事医疗城康复中心、阿卜杜勒阿齐兹国王医疗城康复中心、国民警卫队(利雅得)、法赫德国王医疗城康复医院(利雅得)、沙特国王医疗综合体、哈达康复医院军事医院(塔伊夫)和利雅得护理医院。随着沙特人中脊髓损伤病例的不断增加,研究进展预计将导致推出适当的管理计划、有效实施初级预防策略以及针对创伤性疾病适当分配卫生资源。

< p>本次市场研究中介绍的欧洲和中东慢性疼痛脊髓刺激设备市场的领先公司包括波士顿科学公司 (Boston Scientific Corp)、雅培实验室 (Abbott Laboratories)、美敦力公司 (Medtronic Plc)、Curonix LLC、Biotronik SE & Co. Co KG、Nevro Corp、Nalu Medical Inc、Cirtec Medical Corp 和 Synapse Biomedical Inc.

  • 2020 年 9 月,波士顿科学公司宣布在欧洲市场推出脊髓刺激器 (SCS) 系统的 WaveWriter Alpha 产品组合。该产品组合包括四个 MRI、支持蓝牙的植入式脉冲发生器 (IPG),以及基于患者需求的其他个性化选项。需要。这些系统有可充电/不可充电两种选择,可覆盖多个疼痛部位。
  • 2023 年 10 月,波士顿科学公司 (Boston Scientific Corp) 获得美国 FDA 批准使用 WaveWriter Alpha SCS 系统进行治疗疼痛性糖尿病周围神经病 (DPN) 是一种会影响身体下肢的疾病。
  • 2022 年 8 月,雅培实验室 (Abbott Laboratories) 的 Proclaim Plus SCS 系统获得美国 FDA 批准治疗慢性疼痛。该设备采用 BurstDR 刺激技术,可提供卓越的疼痛缓解效果。它采用 FlexBurst360 疗法,可覆盖躯干和四肢的疼痛,并可根据患者不断变化的治疗需求进行调整。

公司简介

  • 波士顿科学公司
  • 雅培实验室
  • 美敦力公司
  • Curonix LLC
  • Biotronik SE 和 Biotronik Co KG
  • Nevro Corp
  • Nalu Medical Inc
  • Cirtec Medical Corp
  • < span>Synapse 生物医学公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Europe and Middle East spinal cord stimulation devices for chronic pain?

A spinal cord stimulation device is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain. A spinal cord stimulator is mostly used after non-surgical pain treatment options that have failed to provide sufficient relief. Additionally, a spinal cord stimulator can improve the overall quality of life and sleep reduce the need for pain medicines, and it is typically used along with other pain management treatments.

What are the driving factors for the Europe and Middle East spinal cord stimulation devices for chronic pain market across the globe?

Key factors that are driving the growth of this market are rising number of spinal cord injuries and availability of innovative treatments in the European Union (EU).

What is the market CAGR value of Europe and Middle East spinal cord stimulation devices for chronic pain market during forecast period?

The CAGR value of the Europe and Middle East spinal cord stimulation devices for chronic pain market during the forecasted period of 2020-2030 is 7.3%.

Which product type segment leads the Europe and Middle East spinal cord stimulation devices for chronic pain market?

The rechargeable segment held the largest share of the market in the Europe and Middle East spinal cord stimulation devices for chronic pain market and held the largest market share in 2022.

Which end user held the largest share in the Europe and Middle East spinal cord stimulation devices for chronic pain market?

The hospital segment dominated the Europe and Middle East spinal cord stimulation devices for chronic pain market and held the largest market share in 2022.

Who are the key players in the Europe and Middle East spinal cord stimulation devices for chronic pain market?

The Europe and Middle East spinal cord stimulation devices for chronic pain market majorly consists of the players such Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Curonix LLC, Biotronik SE & Co KG, Nevro Corp, Nalu Medical Inc, Cirtec Medical Corp, and Synapse Biomedical Inc.

Which are the top companies that hold the market share in Europe and Middle East spinal cord stimulation devices for chronic pain market?

Boston Scientific Corp and Abbott Laboratories are the top two companies that hold huge market shares in the Europe and Middle East spinal cord stimulation devices for chronic pain market.

The List of Companies - Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market

  1. Boston Scientific Corp
  2. Abbott Laboratories
  3. Medtronic Plc
  4. Curonix LLC
  5. Biotronik SE & Co KG
  6. Nevro Corp
  7. Nalu Medical Inc  
  8. Cirtec Medical Corp
  9. Synapse Biomedical Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports